What is the appropriate evaluation and management for a woman in her 40s presenting with six months of increased hair loss?

Approach to Women in 40s with Increased Hair Loss for 6 Months

Begin with a focused clinical evaluation to distinguish between the most common causes in this demographic: telogen effluvium, female pattern hair loss (androgenetic alopecia), and chronic telogen effluvium, as these account for the majority of diffuse alopecia cases in adult women. 1

Initial Clinical Assessment

History - Key Elements to Elicit

• Chronology and pattern of hair loss: Abrupt, rapid shedding 2-3 months after a triggering event (childbirth, fever, surgery, severe illness) suggests telogen effluvium, while gradual diffuse thinning with central scalp involvement or widening of the central part suggests female pattern hair loss 2, 1

• Triggering events: Specifically ask about recent pregnancy, major surgery, high fever, severe illness, crash dieting, or medication changes 1

• Medication history: Drug-induced anagen effluvium can mimic diffuse alopecia 3

• Psychological impact: Assess for anxiety, depression, and social/work-related problems, as hair loss significantly affects quality of life in women 3, 2

Physical Examination - Specific Findings

• Scalp examination: Normal-appearing scalp with plenty of remaining hair despite excessive shedding suggests chronic telogen effluvium; central scalp thinning with frontal hairline preservation suggests female pattern hair loss 4, 1

• Pull test: Gently pull 50-60 hairs from different scalp areas; more than 6 hairs removed is abnormal and suggests active shedding 2

• Examination of shed hair bulbs: Club hairs (telogen hairs) indicate telogen effluvium 1

• Signs of hyperandrogenism: Check for acne, hirsutism, irregular menses (suggests PCOS or other endocrine disorder) 4

• Dermoscopy/Trichoscopy: Hair miniaturization (progressive decrease in hair shaft diameter) indicates female pattern hair loss 4, 1

Laboratory Evaluation

Order the following screening tests in all cases of diffuse hair loss without a discernible cause: 1

• Complete blood count 1
• Serum ferritin (iron deficiency commonly associated with diffuse hair loss) 1
• Thyroid function tests (TSH, T3, T4) - thyroid disorders are common causes often without obvious clinical features 1
• Routine urinalysis 1

Additional Testing When Indicated

• Androgen levels (total testosterone, free testosterone, DHEA-S) if signs of hyperandrogenism are present or PCOS is suspected 4

• Prolactin level if menstrual irregularities or galactorrhea present 4

Note: Routine iron testing is NOT recommended for alopecia areata specifically, as studies have not confirmed increased iron deficiency in this population 3

Differential Diagnosis - Key Distinguishing Features

Telogen Effluvium

• Abrupt onset 2-3 months post-trigger 1
• Self-limited, resolves in 3-6 months if trigger removed 1
• Positive pull test with club hairs 2

Female Pattern Hair Loss (Androgenetic Alopecia)

• Gradual onset with central scalp thinning 4, 1
• Frontal hairline typically retained 4
• Trichoscopy shows hair miniaturization 4
• Only one-third have abnormal androgen levels 4

Chronic Telogen Effluvium

• Excessive, alarming shedding from normal-looking scalp with plenty of hair 1
• No obvious triggering cause 1
• Duration 3-10 years, may resolve spontaneously 1
• Normal scalp biopsy (differentiates from female pattern hair loss) 1

Alopecia Areata (Diffuse Presentation)

• Can present as diffuse hair loss, though less common 3
• Look for exclamation mark hairs at margins 3
• Dermoscopy shows yellow dots, dystrophic hairs 3

Other Considerations

• Trichotillomania: Incomplete hair loss, broken hairs firmly anchored in anagen phase 3
• Tinea capitis: Scalp inflammation (may be subtle) 3
• Systemic lupus erythematosus: Consider if other systemic symptoms 3

When to Perform Scalp Biopsy

Obtain scalp biopsy when: 4, 1

• Clinical evaluation does not provide definitive diagnosis
• Differentiating chronic telogen effluvium from female pattern hair loss (biopsy shows normal histology in chronic telogen effluvium vs. miniaturization with terminal:vellus ratio <4:1 in female pattern hair loss)
• Suspecting cicatricial alopecia
• Suspecting diffuse alopecia areata

Management Principles

For Telogen Effluvium

• Reassurance and patient education that this represents excessive shedding, not actual permanent hair loss, and does not lead to baldness 1
• Remove or treat the trigger 1
• Repeated support and explanation are guiding principles 3, 1
• Spontaneous resolution expected in 3-6 months 1

For Female Pattern Hair Loss

• Topical minoxidil 2% is first-line treatment 1
• Oral anti-androgens are important therapeutic options 4
• Additional options: finasteride, hair prosthesis, hair cosmetics, hair surgery 1

For Chronic Telogen Effluvium

• Reassurance and support - emphasize this is excessive shedding, not baldness 1
• Prognosis less certain; may take 3-10 years for spontaneous resolution 1

Psychological Support

• Essential component of management given significant impact on anxiety, depression, and quality of life 3, 2
• Explain hair cycle basics and need for patience for cosmetic recovery 2
• Consider referral for psychological support if profoundly distressed 3

Common Pitfalls to Avoid

• Do not routinely screen for autoimmune diseases in alopecia areata without clinical indication 3
• Do not routinely test iron status in alopecia areata specifically, as evidence does not support this 3
• Do not assume all diffuse hair loss is the same - careful history distinguishes telogen effluvium (acute trigger) from female pattern hair loss (gradual onset) from chronic telogen effluvium (excessive shedding without cause) 2, 1
• Recognize psychogenic pseudoeffluvium - patients seeking advice without convincing evidence of actual hair loss may have underlying psychological disorder 2